Price, K. A. R., Harrington, K. J., Worden, F. P., Mesia, R., Even, C., Schaaf, D., Jones, S., Saba, N. F., Haddad, R. I. (2025). VERSATILE-003: A phase 3, randomized, open-label trial of PDS0101 and pembrolizumab compared with pembrolizumab for first-line treatment of patients with HPV16-positive recurrent/metastatic head and neck squamous cell carcinoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps6111